 |
|
CSF Monoamine Metabolites in Movement Disorders and Normal Aging
Stephen M. Stahl, MD, PhD;
Kym F. Faull, PhD;
Jack D. Barchas, MD;
Philip A. Berger, MD
Arch Neurol. 1985;42(2):166-169.
Abstract
• We measured four monoamine metabolite levels in CSF before and after probenecid administration to normal controls and to patients with Huntington's disease (HD), dystonia, and tardive dyskinesia. We identified differences only for the dopamine metabolite homovanillic acid (HVA), which showed increased baseline values and decreased turnover in normal aging, but decreased baseline values and normal turnover in HD. These results suggest that dopamine neurons are linked both to normal aging and to HD and that CSF HVA studies can distinguish differences in the functioning of dopamine neurons in normal aging and HD.
Author Affiliations
From the Stanford Mental Health Clinical Research Center (Drs Stahl and Berger), the Nancy Pritzker Laboratory of Behavioral Neurochemistry (Drs Faull and Barchas), Department of Psychiatry and Behavioral Sciences, Stanford (Calif) University Medical Center, and the Schizophrenia Biologic Research Center, Veterans Administration Medical Center, Palo Alto, Calif (Drs Stahl and Berger).
Footnotes
Accepted for publication March 22, 1984.
Reprint requests to Psychiatry Service 4B2, VA Medical Center, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr Stahl).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Brain Delivery of Homovanillic Acid to Cerebrospinal Fluid During Human Aging
Marti et al.
Arch Neurol 2005;62:690-690.
FULL TEXT
Predictability of Phenotype in Huntington's Disease
Farrer and Conneally
Arch Neurol 1987;44:109-113.
ABSTRACT
Neurochemistry of Dopamine in Huntington's Dementia and Normal Aging
Stahl et al.
Arch Gen Psychiatry 1986;43:161-164.
ABSTRACT
|
